← Back to directory

Manel Sabaté

Researcher Next ID · RN-035236

Researcher · Medicine

Institut d'Investigació Biomédica de Bellvitge

Barcelona, Spain

Accepting doctoral researchersFunding unknown
Works count
899
Citation count
29,704
H-index
78
i10-index
333

Research interests

Medicine
Coronary Interventions and Diagnostics
Cardiac Imaging and Diagnostics
Acute Myocardial Infarction Research
Cardiac Valve Diseases and Treatments
Antiplatelet Therapy and Cardiovascular Diseases

Publications

  • Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease

    New England Journal of Medicine · 2019 · https://doi.org/10.1056/nejmoa1909406

  • Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial

    The Lancet · 2019 · https://doi.org/10.1016/s0140-6736(19)31997-x

  • Drug-eluting or bare-metal stents for percutaneous coronary intervention: a systematic review and individual patient data meta-analysis of randomised clinical trials

    The Lancet · 2019 · 10.1016/s0140-6736(19)30474-x

  • Drug-eluting or bare-metal stents for percutaneous coronary intervention: a systematic review and individual patient data meta-analysis of randomised clinical trials

    The Lancet · 2019 · 10.1016/s0140-6736(19)30474-x

  • Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trial

    The Lancet · 2017 · 10.1016/s0140-6736(17)32713-7

  • Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study

    European Heart Journal · 2017 · https://doi.org/10.1093/eurheartj/ehx512

  • Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease

    New England Journal of Medicine · 2016 · https://doi.org/10.1056/nejmoa1610227

  • Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial

    The Lancet · 2016 · https://doi.org/10.1016/s0140-6736(16)32050-5

  • Absorb Bioresorbable Vascular Scaffold Versus Everolimus-Eluting Metallic Stent in ST-Segment Elevation Myocardial Infarction: 1-Year Results of a Propensity Score Matching Comparison

    JACC: Cardiovascular Interventions · 2015 · https://doi.org/10.1016/j.jcin.2014.10.005

  • Bivalirudin or Unfractionated Heparin in Acute Coronary Syndromes

    New England Journal of Medicine · 2015 · https://doi.org/10.1056/nejmoa1507854

  • Comparison of a Novel Biodegradable Polymer Sirolimus-Eluting Stent With a Durable Polymer Everolimus-Eluting Stent

    Circulation Cardiovascular Interventions · 2015 · https://doi.org/10.1161/circinterventions.114.001441

  • Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011: current status in 37 ESC countries

    European Heart Journal · 2014 · https://doi.org/10.1093/eurheartj/eht529

  • The 2011-12 pilot European Sentinel Registry of Transcatheter Aortic Valve Implantation: in-hospital results in 4,571 patients

    EuroIntervention · 2013 · https://doi.org/10.4244/eijv8i12a209

  • Consensus document on the radial approach in percutaneous cardiovascular interventions: position paper by the European Association of Percutaneous Cardiovascular Interventions and Working Groups on Acute Cardiac Care** and Thrombosis of the European Society of Cardiology

    EuroIntervention · 2013 · 10.4244/eijv8i11a192

  • Clinical Outcomes With Bioabsorbable Polymer- Versus Durable Polymer-Based Drug-Eluting and Bare-Metal Stents

    Journal of the American College of Cardiology · 2013 · 10.1016/j.jacc.2013.09.061

  • Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial

    The Lancet · 2012 · https://doi.org/10.1016/s0140-6736(12)61223-9

  • Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis

    The Lancet · 2012 · https://doi.org/10.1016/s0140-6736(12)60324-9

  • Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis

    BMJ · 2008 · 10.1136/bmj.a1331

  • Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis

    The Lancet · 2007 · https://doi.org/10.1016/s0140-6736(07)61444-5

  • Impact of Platelet Reactivity on Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease

    Journal of the American College of Cardiology · 2007 · 10.1016/j.jacc.2007.05.049

  • Analysis of 14 Trials Comparing Sirolimus-Eluting Stents with Bare-Metal Stents

    New England Journal of Medicine · 2007 · https://doi.org/10.1056/nejmoa067484

  • Insulin Therapy Is Associated With Platelet Dysfunction in Patients With Type 2 Diabetes Mellitus on Dual Oral Antiplatelet Treatment

    Journal of the American College of Cardiology · 2006 · 10.1016/j.jacc.2006.03.038

  • Drug-eluting stent thrombosis

    Journal of the American College of Cardiology · 2005 · 10.1016/j.jacc.2004.11.065

  • Randomized Comparison of Sirolimus-Eluting Stent Versus Standard Stent for Percutaneous Coronary Revascularization in Diabetic Patients

    Circulation · 2005 · https://doi.org/10.1161/circulationaha.105.562421

  • Platelet Function Profiles in Patients With Type 2 Diabetes and Coronary Artery Disease on Combined Aspirin and Clopidogrel Treatment

    Diabetes · 2005 · 10.2337/diabetes.54.8.2430

  • Late Coronary Occlusion After Intracoronary Brachytherapy

    Circulation · 1999 · 10.1161/01.cir.100.8.789

Current projects

    No projects listed.